Form D — Navega Therapeutics, Inc.
0002107977-26-000001 · filed 2026-01-30
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $2,500,000
- Total sold
- $1,300,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Navega Therapeutics, Inc.
- CIK
- 2107977
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 3210 MERRYFIELD ROW
SAN DIEGO, CA 92121 - Phone
- 858-242-1578
Related persons
-
Ana Moreno · Executive OfficerSan Diego, CA
-
Fernando Aleman · Executive OfficerSan Diego, CA
-
Randy Socol · Executive OfficerSan Diego, CA
View original on SEC EDGAR.